Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Laine

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Archives of Cardiovascular Diseases|June 29, 2019
Is there still a role for the intra-aortic balloon pump in the management of cardiogenic shock following acute coronary syndrome?Guillaume Leurent, Vincent Auffret, Camille Pichard, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2013
Tailoring antiplatelet therapy--insanity or good sense?Marc Laine, Richard Toesca, Corinne Frere, et al.
International Journal of Cardiology|January 3, 2015
Antiplatelet properties of oral anticoagulantsCorinne Frère, Marc Laine, Franck Paganelli, et al.
International Journal of Cardiology|September 15, 2012
Biological efficacy and clinical safety of a second 600 mg loading dose of clopidogrel in elderly patients with high on-treatment platelet reactivity: a pilot studyMarc Laine, Franck Paganelli, Françoise Dignat George, et al.
Archives of Cardiovascular Diseases|February 26, 2021
Antithrombotic strategies in elderly patients with acute coronary syndromeJean-Guillaume Dillinger, Marc Laine, Sara Bouajila, et al.
Current Pharmaceutical Design|June 26, 2012
Tailoring antiplatelet therapy: a step toward individualized therapy to improve clinical outcome?Marc Laine, Laurence Camoin-Jau, Jacques Bessereau, et al.
International Journal of Cardiology|December 1, 2012
Improved biological efficacy of prasugrel one month after an acute coronary syndromeMarc Laine, Mouhamadou Nazirou Doddo Siddo, Franck Paganelli, et al.
Expert Opinion on Pharmacotherapy|December 5, 2018
Bivalirudin during percutaneous coronary intervention in acute coronary syndromesMarc Laine, Gilles Lemesle, Thibaut Dabry, et al.
Journal of Cardiovascular Translational Research|November 15, 2012
Clinical impact of genetically determined platelet reactivityMarc Laine, Sébastien Arméro, Michaël Peyrol, et al.
Current Vascular Pharmacology|January 19, 2018
Mechanical Support in Cardiogenic Shock Complicating Acute Coronary Syndrome: Ready for Prime Time?Guillaume Schurtz, Marc Laine, Clement Delmas, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Archives of Cardiovascular Diseases|June 29, 2019
Is there still a role for the intra-aortic balloon pump in the management of cardiogenic shock following acute coronary syndrome?Guillaume Leurent, Vincent Auffret, Camille Pichard, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2013
Tailoring antiplatelet therapy--insanity or good sense?Marc Laine, Richard Toesca, Corinne Frere, et al.
International Journal of Cardiology|January 3, 2015
Antiplatelet properties of oral anticoagulantsCorinne Frère, Marc Laine, Franck Paganelli, et al.
International Journal of Cardiology|September 15, 2012
Biological efficacy and clinical safety of a second 600 mg loading dose of clopidogrel in elderly patients with high on-treatment platelet reactivity: a pilot studyMarc Laine, Franck Paganelli, Françoise Dignat George, et al.
Archives of Cardiovascular Diseases|February 26, 2021
Antithrombotic strategies in elderly patients with acute coronary syndromeJean-Guillaume Dillinger, Marc Laine, Sara Bouajila, et al.
Current Pharmaceutical Design|June 26, 2012
Tailoring antiplatelet therapy: a step toward individualized therapy to improve clinical outcome?Marc Laine, Laurence Camoin-Jau, Jacques Bessereau, et al.
International Journal of Cardiology|December 1, 2012
Improved biological efficacy of prasugrel one month after an acute coronary syndromeMarc Laine, Mouhamadou Nazirou Doddo Siddo, Franck Paganelli, et al.
Expert Opinion on Pharmacotherapy|December 5, 2018
Bivalirudin during percutaneous coronary intervention in acute coronary syndromesMarc Laine, Gilles Lemesle, Thibaut Dabry, et al.
Journal of Cardiovascular Translational Research|November 15, 2012
Clinical impact of genetically determined platelet reactivityMarc Laine, Sébastien Arméro, Michaël Peyrol, et al.
Current Vascular Pharmacology|January 19, 2018
Mechanical Support in Cardiogenic Shock Complicating Acute Coronary Syndrome: Ready for Prime Time?Guillaume Schurtz, Marc Laine, Clement Delmas, et al.
Pageof 9